L'intérêt à découvert pour AdaptHealth donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de AdaptHealth. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

AdaptHealth (NASDAQ:AHCO) Stock, Rapport sur les intérêts à découvert

ADAPTHEALTH CORP

AdaptHealth

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

AdaptHealth Corp

AIMDW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

AIMD

Texas Pacific Land (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) has outperformed the market over the past 10 years by 40.24% on an annualized basis producing an average annual return of 51.72%. Currently, Texas Pacific Land has a market capitalization of $24.26 billion. 
Buying $100 In TPL: If an investor had bought $100 of TPL stock 10 years ago, it would be worth $6,451.34 today based on a price of $1055.44 for TPL at the time of writing.
<h3>Texas Pacific Land's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751067910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

Motorola Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) has outperformed the market over the past 20 years by 27.24% on an annualized basis producing an average annual return of 35.73%. Currently, Motorola Solutions has a market capitalization of $69.63 billion. 
Buying $1000 In MSI: If an investor had bought $1000 of MSI stock 20 years ago, it would be worth $450,172.04 today based on a price of $417.01 for MSI at the time of writing.
<h3>Motorola Solutions's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751067014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) has outperformed the market over the past 10 years by 2.2% on an annualized basis producing an average annual return of 13.68%. Currently, Lululemon Athletica has a market capitalization of $29.44 billion. 
Buying $100 In LULU: If an investor had bought $100 of LULU stock 10 years ago, it would be worth $361.29 today based on a price of $235.00 for LULU at the time of writing.
<h3>Lululemon Athletica's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751066110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LULU

$100 Invested In Lululemon Athletica 10 Years Ago Would Be Worth This Much Today

ExlService Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXLS#NASDAQ">EXLS</a>) has outperformed the market over the past 15 years by 6.18% on an annualized basis producing an average annual return of 18.84%. Currently, ExlService Hldgs has a market capitalization of $7.13 billion. 
Buying $1000 In EXLS: If an investor had bought $1000 of EXLS stock 15 years ago, it would be worth $12,775.51 today based on a price of $43.82 for EXLS at the time of writing.
<h3>ExlService Hldgs's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751065214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXLS

$1000 Invested In ExlService Hldgs 15 Years Ago Would Be Worth This Much Today

HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) has outperformed the market over the past 10 years by 1.37% on an annualized basis producing an average annual return of 12.85%. Currently, HealthEquity has a market capitalization of $9.09 billion. 
Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,276.48 today based on a price of $104.88 for HQY at the time of writing.
<h3>HealthEquity's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751064312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In HealthEquity 10 Years Ago Would Be Worth This Much Today

Scott Galloway had a plan: sell his company, take $25 million, raise another $250 million, and become a billionaire. But then he stopped to think about it. &#8220;Why would I want back on this hamster wheel of stress?&#8221; he asked on a recent episode of his <a href="https://www.youtube.com/watch?v=736vqEuvNq0">podcast</a>, &#8220;Office Hours.&#8221;
<h2 class="wp-block-heading">Chasing Money, Losing Time</h2>
Galloway, a business professor, entrepreneur and <a href="https://www.benzinga.com/news/topics/25/06/45748195/i-bought-netflix-at-12-and-sold-at-10-now-its-at-1100-says-scott-galloway-hates-when-people-only-post-their-wins-online">investor</a>, said he realized the pursuit of more wealth would just cost him time, peace of mind and family moments. &#8220;I&#8217;ve been doing nothing but working for a quarter century,&#8221; he said. After hitting his personal financial target, he made a different choice: spend on what brings joy, pay people well, and give the rest away.
&#8220;I hit my number eight years ago,&#8221; he said. &#8220;And I decided there&#8217;s just no reason why I would ever need to be a billionaire.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
&#8220;Every year I look at my number,&#8221; he explained. &#8220;Anything above that number, I do one of two things: I either spend it or I give it away.&#8221;
He added, &#8220;It feels amazing to spend money and to give it away.&#8221; He owns a plane and refuses to let money prevent him from enjoying life. When friends can&#8217;t afford to join, he covers the cost himself, saying it gives him satisfaction.
<h2 class="wp-block-heading">The Billionaire Trap</h2>
His shift in mindset mirrors that of Andrew Wilkinson, a Canadian entrepreneur who told his own story in the 2024 book, &#8220;Never Enough.&#8221; Wilkinson became a billionaire after building the tech conglomerate Tiny, but eventually saw the limits of wealth.
After nearly partnering with legendary investor Charlie Munger, Wilkinson said he turned it down. The thought of chasing another level of wealth no longer appealed to him.
Both Wilkinson and Galloway reached a similar conclusion. Once you have enough, more doesn&#8217;t necessarily improve your life. In fact, it can increase stress.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
Galloway recalls the fear he felt in 2008 when his first son was born during the financial crisis. &#8220;All I felt was shame and fear,&#8221; he said. &#8220;I thought, I&#8217;ve failed this kid. I don&#8217;t have enough money.&#8221; That fear stayed with him until he reached financial security.
&#8220;Happiness is not only a function of the things you have,&#8221; he said. &#8220;It&#8217;s a function of the things that you don&#8217;t have—specifically, an absence from stress.&#8221;
<h2 class="wp-block-heading">Talking About Money Matters</h2>
Galloway also wants to normalize <a href="https://www.benzinga.com/money/loud-budgeting">open conversations about money</a>. &#8220;This zeitgeist that you&#8217;re not supposed to talk about money is nothing but an effort by rich people to keep the poor and middle class down,&#8221; he said.
He encourages people to <a href="https://www.benzinga.com/personal-finance/management/25/06/45929823/the-salary-a-single-person-needs-to-live-comfortably-now-outweighs-median-annual-wages-in-all-50-states">share information about salaries</a>, taxes and <a href="https://www.benzinga.com/pro/">financial tools to help each other get ahead</a>. &#8220;Talking about it a lot gives you ideas and opportunities and can be quite cathartic,&#8221; he said.
These days, Galloway says he&#8217;s off the hamster wheel for good. He spends on joy, gives generously and says he finally feels free.
Read Next:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

Scott Galloway Reached His Financial Goal 8 Years Ago. He Says There's Just No Justification For Becoming A Billionaire

Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 2.78% on an annualized basis producing an average annual return of 14.26%. Currently, Marsh &amp; McLennan Cos has a market capitalization of $106.91 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 10 years ago, it would be worth $3,791.86 today based on a price of $216.97 for MMC at the time of writing.
<h3>Marsh &amp; McLennan Cos's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751063412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Marsh & McLennan Cos Stock In The Last 10 Years

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 17.33% on an annualized basis producing an average annual return of 25.82%. Currently, Intuitive Surgical has a market capitalization of $191.75 billion. 
Buying $1000 In ISRG: If an investor had bought $1000 of ISRG stock 20 years ago, it would be worth $98,896.23 today based on a price of $535.00 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751062512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ISRG

Here's How Much $1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth Today

Emerson Radio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MSN#AMEX">MSN</a>) reported quarterly losses of $(0.11) per share. This is a 175 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $1.846 million in sales this quarter. This is a 16.13 percent decrease over sales of $2.201 million the same period last year.

Earnings

Emerson Radio Q4 EPS $(0.11) Down From $(0.04) YoY, Sales $1.846M Down From $2.201M YoY

General

SNFCA

Security National Financial To Join Russell 3000 Index, Effective On June 30, 2025

Mexco Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) reported quarterly earnings of $0.30 per share. This is a 150 percent increase over earnings of $0.12 per share from the same period last year. The company reported $1.990 million in sales this quarter. This is a 10.97 percent increase over sales of $1.793 million the same period last year.

Mexco Energy Q4 EPS $0.30 Up From $0.12 YoY, Sales $1.990M Up From $1.793M YoY

In the current market session, Automatic Data Processing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) share price is at $303.50, after a 0.17% increase. Moreover, over the past month, the stock fell by 6.78%, but in the past year, went up by 28.76%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751061620_0.png" alt="Past Year Chart" />

<h3>Comparing Automatic Data Processing P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Automatic Data Processing has a lower P/E than the aggregate P/E of 50.05 of the Professional Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751061620_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for Automatic Data Processing

IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $330.000 thousand which beat the analyst consensus estimate of $305.000 thousand by 8.20 percent. This is a 11.86 percent increase over sales of $295.000 thousand the same period last year.

Earnings Beats

IGC Pharma Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $330.000K Beat $305.000K Estimate

Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) has outperformed the market over the past 15 years by 4.63% on an annualized basis producing an average annual return of 17.29%. Currently, Arch Capital Group has a market capitalization of $33.85 billion. 
Buying $1000 In ACGL: If an investor had bought $1000 of ACGL stock 15 years ago, it would be worth $10,819.65 today based on a price of $90.32 for ACGL at the time of writing.
<h3>Arch Capital Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751060713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACGL

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Insider Trades

Walmart Form4 Filing Shows Walton Family Holdings Trust Sold 378,639 Shares At An Average Price Of $97.52/Share

CBRE Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.25%. Currently, CBRE Group has a market capitalization of $41.55 billion. 
Buying $1000 In CBRE: If an investor had bought $1000 of CBRE stock 5 years ago, it would be worth $3,150.54 today based on a price of $139.38 for CBRE at the time of writing.
<h3>CBRE Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751059848_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

AdaptHealth

Intérêt court

AdaptHealth (NASDAQ:AHCO) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL